- Filed
- Oct 24, 2025 12:00 AM ET
- Period of report
- —
Amendment.
Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Oct 17, 2025 | 100.87M sh |
| Shares Diluted | Q1 2025 · Mar 31, 2025 | 78.95M sh |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 76.37M sh |
| Operating Cash Flow | Q1 2025 · Mar 31, 2025 | −$1.43M |
| Operating Cash Flow restated | Q1 2025 · Mar 31, 2024 | −$4.75M |
| Short Term Investments | Q1 2025 · Mar 31, 2025 | $0 |
| Short Term Investments | Q1 2025 · Dec 31, 2024 | $587.36K |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $24.62K |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $604.49K |
| Stockholders Equity restated | Q1 2025 · Mar 31, 2025 | −$84.08M |
| Stockholders Equity restated | Q1 2025 · Dec 31, 2024 | −$79.49M |
| Current Liabilities restated | Q1 2025 · Mar 31, 2025 | $85.97M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $84.8M |
| Total Liabilities restated | Q1 2025 · Mar 31, 2025 | $289.26M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $286.92M |
| Current Assets restated | Q1 2025 · Mar 31, 2025 | $8.63M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $11.33M |
| Total Assets restated | Q1 2025 · Mar 31, 2025 | $203.62M |
| Total Assets restated | Q1 2025 · Dec 31, 2024 | $205.87M |
| Eps Diluted | Q1 2025 · Mar 31, 2025 | −$0.08 |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.09 |
| Sga Expense | Q1 2025 · Mar 31, 2025 | $3.21M |
| Sga Expense restated | Q1 2025 · Mar 31, 2024 | $3.72M |
| Net Income | Q1 2025 · Mar 31, 2025 | −$6.66M |
| Net Income restated | Q1 2025 · Mar 31, 2024 | −$7.02M |
| Operating Income | Q1 2025 · Mar 31, 2025 | −$4.98M |
| Operating Income restated | Q1 2025 · Mar 31, 2024 | −$6.73M |
| Revenue | Q1 2025 · Mar 31, 2025 | $31.93K |
| Revenue | Q1 2025 · Mar 31, 2024 | $94.02K |